BioSpace News Archive

The report highlights the growth opportunities and challenges that industry players might encounter in the forecast years, along with an elaborate competitive landscape and expansion strategies adopted by the companies functioning in the Pharmaceutical Labeling Market.

Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, today announced a collaboration to accelerate digital pathology adoption at an enterprise scale.

Accord BioPharma announced the hire of several key members of its leadership team: George Esgro Jr. as Senior Vice President of Commercial Operations; Kayla Williams as Executive Director of U.S. Portfolio Strategy and Commercial Development; Nuvan Dassanaike as Senior Vice President of Digital and Marketing Strategy & Operations; and Paul Purdy as Vice President and Head of Market Access.

Saliva may hold the key to understanding and ultimately treating gastrointestinal (GI) disturbance in children with autism spectrum disorder (ASD). A recently published paper showed that specific RNA molecules in the saliva may serve as biomarkers for better understanding the etiology of GI disturbance and eventually guide targeted treatments.

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that a five-person team, led by partner Scott S. Liebman, has joined the firm’s Life Sciences and FDA Regulatory industry teams.

Lyophilization equipment or lyophilizer execute dehydration process that is essential to preserve perishables and make materials more convenient for storage or transport.

3D printed drugs have potential to revolutionize the personalized medicine sector. As the world moves toward the utilization of personalized medicines, market players and researchers across the world took strides toward utilizing 3D printing techniques.

Published online March 9 in Cancer Discovery, a journal of the American Association for Cancer Research, the study found that in melanoma, the deadliest form of skin cancer, cancer cells that have spread to the brain depend on amyloid beta to survive there.

Antisense Therapeutics Limited [ASX: ANP | US OTC: ATHJY | FSE: AWY] will deliver a virtual presentation on its antisense drug at the Muscular Dystrophy Association Clinical & Scientific Conference later this week.

RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that following the review of its research and corporate activities, the Company is taking steps to streamline its clinical, research and development, and administrative operations in order to reduce costs.